Order Durolane Injection for Clinics

Durolane® is a sterile, non-animal stabilized hyaluronic acid gel supplied as a 60 mg/3 mL prefilled syringe for intra-articular administration by trained clinicians. Licensed clinics and healthcare professionals can order Durolane injection for osteoarthritis care pathways that use a single-injection viscosupplement format. The English-labeled syringe supports treatment-room setup, lot documentation, and professional handling in orthopedic, rheumatology, and ambulatory procedure settings.

Each unit is intended for one patient and one joint, helping clinics standardize procedure supply pulls and reduce repeat-visit scheduling compared with multi-injection courses. Med Wholesale Supplies serves licensed healthcare facilities with brand-name medical products sourced through vetted distributors and verified supply channels.

Durolane 60mg/3ml Injection Details

Durolane is a sodium hyaluronate injection based on NASHA, or non-animal stabilized hyaluronic acid. Hyaluronic acid is a naturally occurring component of synovial fluid, where it contributes to lubrication and shock absorption inside movable joints. In viscosupplementation, the gel is injected into the joint space to supplement the joint’s viscoelastic environment during an osteoarthritis management plan.

The supplied format is a Durolane prefilled syringe containing 3 mL of gel with 60 mg of hyaluronic acid. The syringe is sterile and single-use, so any unused portion should be discarded after administration. Because the product is delivered directly into a joint, aseptic technique, accurate placement, and local clinic protocols are central to safe use.

For category planning, clinics can review related orthopedic injections and rheumatology products used across joint-care service lines.

Ordering, Price, and Clinic Logistics

Current prices and quantity breaks are shown on this page, and licensed clinics can order as a guest or with an account. If your team uses standing purchase planning, align quantities with appointment volume, provider schedules, and storage capacity.

Our team can support US distribution needs with temperature-controlled handling when required and tracked US delivery. For multi-site practices, consistent ordering records help reconcile lot numbers, expiry dates, procedure charges, and device documentation across locations.

Quick tip: Match each scheduled procedure to a single sealed syringe so staff can prepare trays without partial-use inventory decisions.

How the NASHA Viscosupplement Works

Durolane hyaluronic acid injection uses a cross-linked NASHA gel designed for residence in the joint space. The gel’s viscoelastic properties help supplement the lubrication and cushioning functions normally associated with synovial fluid. This class is commonly used when a clinician determines that viscosupplementation fits a patient’s osteoarthritis care plan.

In knee osteoarthritis programs, a Durolane single injection approach can reduce visit burden compared with multi-week injection series. The single-injection format may simplify scheduling, consent workflow, supply picking, and follow-up planning. Procedure teams may also use imaging guidance when site localization is appropriate under their institutional protocols.

Clinical decision-making should remain patient-specific. Providers typically evaluate the involved joint, symptom pattern, prior conservative measures, medical history, infection risk, and any payer or formulary requirements before selecting a viscosupplement. For additional clinical context, see our professional discussion of Durolane hyaluronic acid for knee OA.

Professional Applications and Workflow Fit

Orthopedic, rheumatology, pain-management, and sports-medicine teams may incorporate Durolane into osteoarthritis injection pathways. Typical use involves intra-articular administration into the affected joint by a trained clinician. The syringe format supports in-office procedures, ambulatory suites, and scheduled injection sessions where sterile setup and documentation are already established.

For knee-focused programs, teams can consolidate patient education, consent, skin preparation, injection, and post-procedure instructions into a single appointment when clinically appropriate. This can reduce rebooking steps and makes inventory forecasting more predictable. Practices that rotate providers across sites may benefit from standardized product presentation, consistent labeling, and familiar syringe handling.

Clinic managers often evaluate viscosupplements by visit count, syringe volume, product technology, staff familiarity, and formulary fit. For broader product selection, our Durolane injection discussion and gel injections for knees article outline practical differences across this category.

Key Features for Procedure Rooms

• Sterile, single-use syringe for one patient and one joint.
• 60 mg/3 mL Durolane syringe presentation for single-injection protocols.
• NASHA technology using non-animal stabilized hyaluronic acid.
• English carton and instructions support staff training and documentation.
• Prefilled format reduces manual preparation steps before administration.
• Visible lot and expiry details support traceability in clinic records.
• Sealed packaging helps maintain sterility until point of use.
• Single-visit format may reduce repeat appointment coordination.
• Compatible with standard professional aseptic preparation workflows.
• Appropriate for trained clinician administration only.

The compact carton fits common procedure-room storage systems and medication bins. Staff should keep the syringe sealed until preparation and follow the manufacturer’s instructions for handling, use, and disposal.

Storage, Handling, and Documentation

Store and handle Durolane according to the manufacturer’s carton and instructions for use. Do not freeze the syringe. Clinics should maintain stock rotation practices that prioritize expiry-date visibility and avoid using any unit with damaged packaging, compromised sterility, or unclear labeling.

Documentation usually includes the product name, strength and volume, lot number, expiry date, joint treated, route, clinician, and any post-procedure observations required by local policy. Barcoding or manual entry can support EMR inventory reconciliation when systems allow device or supply tracking.

After administration, discard unused gel and dispose of sharps through standard medical waste procedures. Staff should not resterilize, reuse, or divide a single syringe between patients. If the clinic maintains multiple viscosupplement brands, store each line clearly to reduce substitution errors during busy injection sessions.

Safety, Side Effects, and Precautions

Durolane is administered directly into the joint, so local reactions are the most relevant day-to-day safety considerations. Expected injection-site reactions may include pain, swelling, warmth, redness, itching, bruising, stiffness, or temporary joint discomfort. These events are generally managed according to clinical judgment and local post-procedure protocols.

Clinicians should avoid intra-articular injection through infected skin or into a joint with active infection. Use caution in patients with relevant hypersensitivity history, bleeding risk, anticoagulant use, or conditions that may increase procedural risk. The care team should review the full instructions for use, screen patients according to clinic policy, and maintain aseptic technique throughout the procedure.

Patients are commonly advised by clinicians to avoid strenuous activity involving the treated joint for a short period after injection, but the exact instruction should follow the provider’s protocol. Worsening pain, marked swelling, fever, significant redness, or symptoms suggesting infection require prompt clinical evaluation. Safety documentation should include counseling given, immediate tolerance, and any adverse event reporting steps required by the facility.

Comparing Viscosupplement Choices

Clinics evaluating Durolane often compare it with other hyaluronic acid products based on dosing schedule, syringe volume, polymer technology, and provider familiarity. A single-injection product can be operationally attractive when the service line aims to limit repeat visits. Multi-injection products may remain useful when a clinician, payer, or formulary pathway calls for a different schedule.

Related options include Synvisc-One prefilled syringe, Orthovisc English, and Hyalgan English syringe. Product selection should be led by labeled use, clinical protocol, stocking requirements, and provider assessment rather than convenience alone.

For a focused comparison of single-injection and other joint-pain injection pathways, see Synvisc-One vs Durolane and orthopedic injection choices for knee pain.

Availability and Substitution Planning

Durolane can be incorporated into clinic formularies as a defined syringe presentation with clear ordering and documentation steps. Supply planning should account for scheduled injection volume, provider preference, and any internal approval process used by the facility. If an alternative is selected, confirm that the replacement matches the intended joint-care pathway, route, visit count, and product instructions.

During transitions, update staff education, consent templates, EMR preference lists, and procedure-room pick lists so the product in stock matches the materials used by the team. The Durolane brand page can help purchasing staff keep line-specific information organized during formulary review.

Authoritative Sources

• DUROLANE manufacturer information
• FDA DUROLANE instructions for use
• NIAMS osteoarthritis overview

Ready to order? Choose your quantity above, or call 1-800-630-9757 to talk to our customer service team.

This content is for informational purposes only and is not a substitute for professional medical advice.